Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olesoxime in ALS
NCT00868166Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of olesoxime in amyotrophic lateral sclerosis (ALS), sponsored by Roche. Started Apr 2009; status: completed.
02
Drugs
olesoxime
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00868166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868166.